Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment

Pediatric Blood and Cancer

Volumn 44, Issue 4, 2005, Pages 378-385

  Kennedy, Deborah D ^a   Ladas, Elena J ^a   Rheingold, Susan R ^c   Blumberg, Jeffrey ^b   Kelly, Kara M ^a,d  

^a Columbia University ^*  (United States)

^b TUFTS UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

8 oxo dG; ALL; Antioxidant; Children; Side effects

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CAROTENOID; DNA; RETINOL;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PLASMA; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; TOXICITY; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; CHILD; CHILD, PRESCHOOL; DEOXYGUANOSINE; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; OXIDATIVE STRESS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 14644393599     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20307     Document Type: Article

References (48)

1. Conklin K. Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 2000;37:1-18.
2. World Cancer Research Fund, American Institute for Cancer Research. Vitamins. In: World Cancer Research Fund, American Institute for Cancer Research, editors. Food, nutrition and the prevention of cancer: A global perspective. Washington, DC: American Institute for Cancer Research; 1997. pp 404-416.
3. Kakar S, Wilson C, Bell J. Plasma and leucocyte ascorbic acid concentrations in acute lymphoblastic leukemia. Ir J Med Sci 1975;144:227-232.
4. Nakagawa K. Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia. Cell Mol Biol 2000;46:1375-1381.
5. Senturker S, Karahalil B, Inal M, et al. Oxidative DNA base damage and antioxidant enzyme levels in childhood acute lymphoblastic leukemia. FEBS Lett 1997;416:286-290.
6. Malvy D, Arnaud J, Burtschy B. Antioxidant micronutrients and childhood malignancy during oncological treatment. Med Pediatr Oncol 1997;29:213-217.
7. vanEys J. Benefits of nutritional intervention on nutritional status, quality of life and survival. Int J Cancer Suppl 1998;11:66-68.
8. Hu Z, Yang G, Miyamoto N, et al. Mechanism of cytosine araninoside toxicity to the blast cells of acute myeloblastic leukemia: Involvement of free radicals. Leukemia 1995;9:789-798.
9. Sinha B, Katki A, Batist G, et al. Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: Implications for the mechanism of action. Biochemistry 1987;26:3776-3781.
10. Ollinger K, Brunmark A. Effect of different oxygen pressures and N,N,-Diphenyl-p-phenylenediamine on adriamycin toxicity to cultured neonatal rat heart myocytes. Biochem Pharmacol 1994;48:1707-1715.
11. Patel J, Block E. Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp Lung Res 1985;8:153-165.
12. Venkatesan N, Chandrakasan G. Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 1995;142:79-87.
13. Gressier B, Lebegue S, Brunet C, et al. Pro-oxidant properties of methotrexate: Evaluation and prevention by an anti-oxidant drug. Pharmazie 1994;49:679-681.
14. Bostrom B, Sensel M, Sather H, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 2003;101:3809-3817.
15. Stork L, Sather H, Hutchinson R, et al. Comparison of mercaptopurine with thioguanine and IT methotrexate with IT "triples" in children with standard risk ALL:Results of CCG-1952. Blood 2002;100:36a.
16. Nachman J, Sather H, Sensel M, et al. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med 1998;338:1663-1671.
17. Seibel N, Steinherz P, Sather H, et al. Early treatment intensification improves outcome in children and adolescents with acute lymphoblastic leukemia presenting with unfavorable features who show a rapid early response to induction chemotherapy: A report of CCG 1961. Blood 2003;102:787.
18. Kennedy DD, Tucker K, Ladas E, et al. Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia. Am J Clin Nutr 2004;79:1029-1036.
19. Goodwin D, Boggs S, Graham-Pole J. Development and validation of the pediatric oncology quality of life scale. Psychol Assess 1994;6:321-327.
20. Behrens W, Madere R. A highly sensitive high-performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in tissues, biological fluids and foods. Anal Biochem 1987;165:102-107.
21. Bieri J, Tolliver T, Catignani G. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high-pressure liquid chromatography. Am J Clin Nutr 1979;32:2143-2149.
22. Roels O, Trout M, Lui N, et al. Vitamins and hormones: Vitamin A and carotene. In: MacDonald R, editor. Standard methods of clinical chemistry. New York: Academic Press; 1972.
23. Lopes-Virella M, Stone P, Ellis S, et al. Cholesterol determination in high-density lipoprotein separated by three different methods. Clin Chem 1997;23:882-884.
24. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
25. Cao G, Prior R. Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol 1999;299:50-62.
26. Yin B, Whyatt R, Perera F, et al. Determination of 8- hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody based ELISA. Free Radic Biol Med 1995;18:1023-1032.
27. Yarborough A, Zhang Y, Hsu T, et al. Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1-treated rat liver and human oral mucosal cells. Cancer Res 1996;56:683-688.
28. Motykiewicz G, Faraglia B, Wand L, et al. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA-repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer. Environ Mol Mutagen 2002;40:93-100.
29. Gaynon P, Desai A, Bostrom B, et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia: A review. Cancer 1997;80:1717-1726.
30. Kuczmarski R, Ogden C, Grummer-Strawn L, et al. editors. CDC growth charts: United States. Advance data from vital and health statistics. Hyattsville: National Center for Health Statistics; 2000. 314p.
31. Tietz N, editor. Clinical guide to laboratory tests. Philadelphia: W.B. Saunders Company; 1995. pp 116-647.
32. Malvy D, Burtschy B, Arnaud J, et al. Serum beta-carotene and antioxidant micronutrients in children with cancer. Int J Epidemiol 1993;22:761-771.
33. Combs G. Vitamins. In: Mahan L, Escott-Stump S, editors. Krause's food nutrition, & diet therapy. Philadelphia: WB Saunders Company; 2000. pp 67-109.
34. Fiore P, Castagnola E, Marchese N, et al. Retinol (vitamin A) and retinol-binding protein serum levels in children with cancer at onset. Nutrition 1997;13:17-20.
35. Kuvibidila S, Yu L, Gardner R, et al. Association between increased levels of TNF-alpha, decreased levels of prealbumin and retinol-binding protein, and disease outcome. J Natl Med Assoc 2000;92:485-491.
36. Yu L, Kuvibidila S, Ducos R, et al. Nutritional status of children with leukemia. Med Pediatr Oncol 1994;22:73-77.
37. Halton J, Nazir D, McQueen M, et al. Blood lipid profiles in children with acute lymphoblastic leukemia. Cancer 1998;83:379-384.
38. Cao G, Russell R, Lischner N, et al. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J Nutr 1998;128:2383-2390.
39. Cao G, Sofic E, Prior R. Antioxidant capacity of tea and common vegetables. J Agric Food Chem 1996;44:3426-3431.
40. Rehman A, Bourne L, Halliwell B, et al. Tomato consumption modulates oxidative DNA damage in humans. Biochem Biophys Res Commun 1999;262:828-831.
41. Verhagen H, Poulsen H, Loft S, et al. Reduction of oxidative DNA-damage in humans by Brussels sprouts. Carcinogenesis 1995;16:969-970.
42. van Poppel G, Poulsen H, Loft S, et al. No influence of beta carotene on oxidative DNA damage in male smokers. J Natl Cancer Inst 1995;87:310-311.
43. Prieme H, Loft S, Nyyssonen KJ, et al. No effect of supplementation with vitamin E, ascorbic acid, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2-deoxyguanosine excretion in smokers. Am J Clin Nutr 1997;65:503-507.
44. Guo C, Cao G, Sofic E, et al. High performance liquid chromatography coupled with colometric array detection of electroactive components in fruit and vegetables: Relationship to oxygen radical absorbance capacity. J Agric Food Chem 1997;45:1787-1796.
45. Omenn GS, Goodman G, Thornquist M, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestos-exposed workers. Cancer Res 1994;54:2038s-2043s.
46. Rowe PM. Beta-carotene takes a collective beating. Lancet 1996; 347:249.
47. Albanes D, Heinonen O, Huttlenen J, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene prevention study. Am J Clin Nutr 1995;62:1427S-1430S.
48. Tsuchida T, Saito M, Honda H, et al. Chemoprevention of lung cancer. Gan To Kagaku Ryoho 2003;30:181-184.